Tarsus Pharmaceuticals, Inc. Quarterly Interest Expense in USD from Q3 2021 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Tarsus Pharmaceuticals, Inc. quarterly/annual Interest Expense history and growth rate from Q3 2021 to Q1 2024.
  • Tarsus Pharmaceuticals, Inc. Interest Expense for the quarter ending March 31, 2024 was $983K, a 43.7% increase year-over-year.
  • Tarsus Pharmaceuticals, Inc. Interest Expense for the twelve months ending March 31, 2024 was $3.65M, a 42% increase year-over-year.
  • Tarsus Pharmaceuticals, Inc. annual Interest Expense for 2023 was $3.35M, a 52.2% increase from 2022.
  • Tarsus Pharmaceuticals, Inc. annual Interest Expense for 2022 was $2.2M.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $3.65M $983K +$299K +43.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $3.35M $989K +$283K +40.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 $3.06M $858K +$225K +35.5% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $2.84M $815K +$271K +49.8% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $2.57M $684K +$368K +116% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $2.2M $706K Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 $633K +$633K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $544K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $316K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q3 2021 $0 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.